Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
CRVO
#3585
CervoMed Inc. Common Stock
3.9
9
-5.00%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-5.00%
Changement Mensuel
-31.91%
Evolution sur 6 mois
-58.13%
Changement Annuel
+83.87%
Clôture Précédente
4.2
0
Open
3.9
9
Bid
Ask
Low
3.9
9
High
3.9
9
Volume
6
Marchés
Actions des Marchés US
Soins de Santé
CRVO
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
8.25 M
8.7 M
8.7 M
9.25 M
9.25 M
—
Valuation ratios
Enterprise value
112.76 M
11.36 M
69.13 M
49.83 M
65.42 M
195.74 M
Price to earnings ratio
-6.92
-1.16
-4.14
-2.38
-2.76
-10.44
Price to sales ratio
7.62
1.94
8.4
6.93
11.25
28.51
Price to cash flow ratio
-7.32
-1.14
-4.06
-2.3
-2.82
-10.32
Price to book ratio
1.23
0.48
0.54
0.35
0.53
1.9
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.1
-0.16
-0.13
-0.16
-0.25
-0.7
Return on equity %
-0.1
-0.17
-0.14
-0.19
-0.3
-0.8
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-278.19
-334.91
-276.55
-376.41
-2 493.79
-3 481.67
EBITDA margin %
—
—
—
—
—
—
Net margin %
-245.06
-310.17
-255.23
-356.05
-2 395.34
-3 316.8
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.93
8.66
8.2
6.05
5
27.91
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0.05
0.05
0.05
0.01
0.15
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.56
-1
-0.45
-0.73
-0.7
-2.87
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
5.36
1.11
4.05
3.74
2.95
11.86
Net current asset value per share
5.61
5.34
4.43
4.25
3.31
17.33
Tangible book value per share
5.24
4.86
3.98
3.74
2.81
15.38
Working capital per share
5.1
4.72
3.89
3.55
2.65
14.81
Book value per share
5.24
4.86
3.98
3.74
2.81
15.38
Nouvelles
CervoMed, UK ALS 임상 플랫폼에 ’neflamapimod’ 선정
CervoMed’s neflamapimod selected for UK ALS trial platform
Cantor Fitzgerald, CervoMed에 ’비중확대’ 의견 제시
Cantor Fitzgerald initiates CervoMed stock with Overweight rating
서보메드, 치매 치료제 임상 시험 결과 발표 후 주가 급등
CervoMed, DLB 치료제 2b상 임상시험서 긍정적 결과
CervoMed’s DLB drug shows promise in phase 2b trial
CervoMed stock soars after promising dementia drug trial results
Neflamapimod reduces key neurodegeneration markers in DLB study
CervoMed CEO 알람, 182,736달러 상당의 주식 매입
CervoMed Inc.: Winton CBO, CRVO 주식 4만 1천 달러 매입
그레고어 실비, CervoMed(CRVO) 주식 182,736달러 상당 매수